Related Experiment Video

Updated: Jun 17, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Hotspot mutations of PIK3CA and AKT1 genes are absent in multiple myeloma

Said I Ismail1, Ismail S Mahmoud, Mohammed M Msallam

  • 1Molecular Biology Research Lab, Department of Biochemistry, University of Jordan, Amman, Jordan. sismail@ju.edu.jo

Leukemia Research
|December 22, 2009
PubMed

Insights

Mutations in the PI3K/AKT pathway, specifically in the PIK3CA and AKT1 genes, were investigated in multiple myeloma patients. The study found no evidence of common hotspot mutations, suggesting this pathway may not be a significant driver in this cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The phosphatidylinositol-3-kinases (PI3K)/AKT pathway is crucial for cellular growth and survival.
  • This pathway is frequently dysregulated in various human cancers, including multiple myeloma.
  • Mutations in the PIK3CA gene, encoding a key PI3K subunit, are observed in numerous malignancies.

Purpose of the Study:

  • To investigate the potential oncogenic role of the PI3K/AKT pathway in multiple myeloma.
  • To identify hotspot mutations in the PIK3CA and AKT1 genes within a cohort of multiple myeloma patients.

Main Methods:

  • Sequencing of three key exons (exons 9 and 20 of PIK3CA, exon 3 of AKT1).
  • Analysis of genetic material from 27 multiple myeloma patients.
  • Screening for four specific hotspot mutations: E542K, E545K, H1047R, and E17K.

Main Results:

  • Absence of the targeted PIK3CA and AKT1 hotspot mutations in all 27 multiple myeloma patients studied.
  • No evidence of E542K, E545K, H1047R, or E17K mutations was detected.

Conclusions:

  • The investigated PI3K/AKT pathway hotspot mutations do not appear to be major drivers in the development or progression of multiple myeloma.
  • Further research may be needed to explore other potential alterations or pathways involved in multiple myeloma pathogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...